- ICH GCP
- US Clinical Trials Registry
- Klinisk forsøg NCT01389206
Pulmonary Arterial Hypertension Quality Enhancement Research Initiative Extension Program (PAH QuERI Ext)
14. august 2018 opdateret af: Actelion
Knowledge Translation Program for the guidelines and evidence-based management of PAH patients
Studieoversigt
Status
Afsluttet
Betingelser
Detaljeret beskrivelse
To improve the management of PAH patients through an evidence-based approach aimed at achieving optimal WHO functional class (defined as: 1) improvement of FC III or IV to FC II; 2) improvement of FC II to FC I; or 3) maintaining FC II or I)
Undersøgelsestype
Observationel
Tilmelding (Faktiske)
797
Kontakter og lokationer
Dette afsnit indeholder kontaktoplysninger for dem, der udfører undersøgelsen, og oplysninger om, hvor denne undersøgelse udføres.
Studiesteder
-
-
Alabama
-
Birmingham, Alabama, Forenede Stater, 35216
- Cardiovascular Associates, Pc
-
Mobile, Alabama, Forenede Stater, 36617
- University of South Alabama Medical Center
-
-
Arizona
-
Phoenix, Arizona, Forenede Stater, 85006
- Pulmonary Associates
-
-
Arkansas
-
Little Rock, Arkansas, Forenede Stater, 72205
- University of Arkansas for Medical Sciences
-
-
California
-
Fountain Valley, California, Forenede Stater, 92866
- Alliance Medical and Research Center
-
La Jolla, California, Forenede Stater, 92037
- Scripps Clinic, Scripps Green Hospital
-
Los Angeles, California, Forenede Stater, 90033
- University of Southern California
-
San Juan Capistrano, California, Forenede Stater, 92675
- Paloma Medical Group
-
Torrance, California, Forenede Stater, 90502
- Harbor-UCLA Medical Center
-
-
Colorado
-
Aurora, Colorado, Forenede Stater, 80045
- University of Colorado Denver
-
Littleton, Colorado, Forenede Stater, 80120
- South Denver Cardiology Associates PC
-
Wheat Ridge, Colorado, Forenede Stater, 80033
- Robert E. Benkert, M.D.P.C.
-
-
Delaware
-
Newark, Delaware, Forenede Stater, 19713
- Lung Health & Sleep Enhancement Center, LLC
-
-
Florida
-
Brandon, Florida, Forenede Stater, 33511
- Bay Area Cardiology Research, P.A.
-
Clearwater, Florida, Forenede Stater, 33756
- Bay Area Chest Physicians
-
Fort Lauderdale, Florida, Forenede Stater, 33316
- Broward Pulmonary and Sleep Specialists
-
Fort Lauderdale, Florida, Forenede Stater, 33334
- Pulmonary Diseases, Internal Medicine, Critical Care Medicine
-
Miami Beach, Florida, Forenede Stater, 33140
- Mount Sinai Medical Centre - Columbia University - Division of Cardiology
-
Orlando, Florida, Forenede Stater, 32803
- Central Florida Pulmonary Group, PA
-
Sarasota, Florida, Forenede Stater, 34239
- Lung Associates of Sarasota
-
Weston, Florida, Forenede Stater, 33331
- Cleveland Clinic Florida
-
-
Illinois
-
Chicago, Illinois, Forenede Stater, 60612
- University of Illinois at Chicago
-
Peoria, Illinois, Forenede Stater, 61602
- Unity Point Health Pulmonary Services
-
-
Indiana
-
Indianapolis, Indiana, Forenede Stater, 46202
- Indiana University
-
-
Iowa
-
Iowa City, Iowa, Forenede Stater, 52301
- University of Iowa Hospitals & Clinics
-
-
Kentucky
-
Louisville, Kentucky, Forenede Stater, 40202
- Kentuckiana Pulmonary Associates
-
Louisville, Kentucky, Forenede Stater, 40202
- University of Louisville School of Medicine
-
-
Louisiana
-
New Orleans, Louisiana, Forenede Stater, 70121
- Ochsner Medical Center
-
-
Maine
-
Portland, Maine, Forenede Stater, 04102
- Maine Medical Center
-
-
Maryland
-
Baltimore, Maryland, Forenede Stater, 21287
- Johns Hopkins University
-
Baltimore, Maryland, Forenede Stater, 21201
- University of Maryland Medical Centre
-
-
Michigan
-
Ann Arbor, Michigan, Forenede Stater, 48109
- University of Michigan Pulmonary Hypertension Program
-
Detroit, Michigan, Forenede Stater, 48324
- Wayne State University, Detroit Medical Center
-
Grand Rapids, Michigan, Forenede Stater, 49525
- Spectrum Health
-
Troy, Michigan, Forenede Stater, 48085
- William Beaumont Hospital - Troy
-
-
Nebraska
-
Lincoln, Nebraska, Forenede Stater, 68506
- Nebraska Pulmonary Specialties, LLC
-
Omaha, Nebraska, Forenede Stater, 68131
- Creighton University Medical Centre - Pulmonary, Critical Care and Sleep Medicine Division
-
Omaha, Nebraska, Forenede Stater, 68198-5300
- University of Nebraska Medical Center
-
-
Nevada
-
Las Vegas, Nevada, Forenede Stater, 89128
- The Lung Center of Nevada
-
-
New Hampshire
-
Lebanon, New Hampshire, Forenede Stater, 03756-0001
- Dartmouth-Hitchcock Medical Center
-
-
New Jersey
-
Bloomfield, New Jersey, Forenede Stater, 07003
- Michael Schwarz, MDFACC
-
Hawthorne, New Jersey, Forenede Stater, 07506
- Respiratory Health & Critical Care Associates
-
Newark, New Jersey, Forenede Stater, 07112
- Pulmonary Hypertension & Lung Transplant Program Newark Beth Israel Medical Center
-
-
New York
-
New Hyde Park, New York, Forenede Stater, 11040
- North Shore - LIJ Health System
-
New York, New York, Forenede Stater, 10003
- Beth Israel Medical Center
-
-
North Carolina
-
Durham, North Carolina, Forenede Stater, 27710
- Duke University Medical Center
-
Greenville, North Carolina, Forenede Stater, 27834
- East Carolina University
-
Winston-Salem, North Carolina, Forenede Stater, 27157
- Wake Forest University Phyisicans Clinic/Pulmonary
-
-
Ohio
-
Cincinnati, Ohio, Forenede Stater, 45219
- The Christ Hospital Heart & Vascular Center
-
Cincinnati, Ohio, Forenede Stater, 45219
- University of Cincinnati Pulmonary Critical Care & Sleep Medicine
-
Cleveland, Ohio, Forenede Stater, 44195
- Cleveland Clinic
-
Cleveland, Ohio, Forenede Stater, 44106
- University Hospitals Case Medical Center
-
Dayton, Ohio, Forenede Stater, 45215
- Dayton Respiratory Center
-
Toledo, Ohio, Forenede Stater, 43614
- University of Toledo Health Sciences Campus
-
-
Oregon
-
Bend, Oregon, Forenede Stater, 97701
- Heart Center Cardiology
-
-
Pennsylvania
-
Doylestown, Pennsylvania, Forenede Stater, 18901
- Central Bucks Specialists - The Pavilion at Doylestown Hospital
-
Langhorne, Pennsylvania, Forenede Stater, 19007
- Institute for Respiratory and Sleep Medicine
-
Philadelphia, Pennsylvania, Forenede Stater, 19140
- Temple University Hospital
-
Philadelphia, Pennsylvania, Forenede Stater, 19104
- Pulmonary Hypertension Program, Cardiology, Children's Hospial of Philadelphia
-
Philadelphia, Pennsylvania, Forenede Stater, 19104
- Pulmonary Vascular Disease Program, Penn Presbyterian Medical Center
-
Pittsburgh, Pennsylvania, Forenede Stater, 15213
- University of Pittsburgh Medical Center
-
Wyomissing, Pennsylvania, Forenede Stater, 19610
- Respiratory Specialists
-
York, Pennsylvania, Forenede Stater, 17402
- Wellspan Lung, Sleep and Critical Care
-
-
Rhode Island
-
Providence, Rhode Island, Forenede Stater, 02903
- Rhode Island Hospital
-
-
South Carolina
-
Charleston, South Carolina, Forenede Stater, 29425
- Medical University of South Carolina
-
-
South Dakota
-
Sioux Falls, South Dakota, Forenede Stater, 57103
- Sioux Falls Cardiovascular PC
-
-
Tennessee
-
Knoxville, Tennessee, Forenede Stater, 37919
- StatCare Pulmonary Consultants
-
-
Texas
-
El Paso, Texas, Forenede Stater, 79902
- El Paso Respiratory and Sleep Consultants
-
Galveston, Texas, Forenede Stater, 77555
- University of Texas Medical Branch
-
Houston, Texas, Forenede Stater, 77030
- Baylor College of Medicine
-
Houston, Texas, Forenede Stater, 77030
- UT Health - University of Texas Houston
-
Waco, Texas, Forenede Stater, 76712
- Providence Health Center
-
-
Virginia
-
Falls Church, Virginia, Forenede Stater, 22042
- IHVI, Advanced Lung Disease and Transplant Clinic
-
Norfolk, Virginia, Forenede Stater, 23507
- Sentara Medical Group
-
-
Washington
-
Puyallup, Washington, Forenede Stater, 98372
- Cardiac Study Center
-
-
-
-
-
San Juan, Puerto Rico, 00918
- PAH Clinic CPR at Auxilio Mutuo
-
-
Deltagelseskriterier
Forskere leder efter personer, der passer til en bestemt beskrivelse, kaldet berettigelseskriterier. Nogle eksempler på disse kriterier er en persons generelle helbredstilstand eller tidligere behandlinger.
Berettigelseskriterier
Aldre berettiget til at studere
18 år og ældre (Voksen, Ældre voksen)
Tager imod sunde frivillige
Ingen
Køn, der er berettiget til at studere
Alle
Prøveudtagningsmetode
Ikke-sandsynlighedsprøve
Studiebefolkning
Approximately 800 PAH patients from approximately 80 physician practices will be included in the program.
Beskrivelse
Inclusion Criteria:
- Male and female adults (≥ 18 years of age)
Documented diagnosis of PAH (all of the following): i. RHC demonstrating mPAP > 25 mm Hg and PCWP
≤ 15 and PVR > 3 ii. FEV 1 > 50% predicted normal iii. V/Q and/or CT scan excluding the thromboembolic etiology
- Diagnosis of PAH < 3 years
- Need for PAH specific treatment
- Desire to participate and signs an informed consent
Exclusion Criteria:
Any of the criteria below:
- Poor mental function, drug or substance (e.g.,alcohol) abuse, or unstable psychiatric illness, which, in the opinion of the investigator, may interfere with optimal participation in the study
- Prior participation in this program
- Patients with pulmonary hypertension classified as group 2 - 5 Updated Clinical Classification of Pulmonary Hypertension (5th World Symposium on PH Modified Classification of PH)
Studieplan
Dette afsnit indeholder detaljer om studieplanen, herunder hvordan undersøgelsen er designet, og hvad undersøgelsen måler.
Hvordan er undersøgelsen tilrettelagt?
Design detaljer
- Observationsmodeller: Kun etui
- Tidsperspektiver: Fremadrettet
Kohorter og interventioner
Gruppe / kohorte |
Intervention / Behandling |
|---|---|
|
Standard of care
Observational study to improve the management of PAH patients through an evidence-based approach aimed at achieving optimal WHO functional class (FC) treated with Tracleer, Ventavis, Veletri, Opsumit and/or Uptravi.
|
observational study with patients treated with Tracleer, Ventavis, Veletri, Opsumit and/or Uptravi
|
Hvad måler undersøgelsen?
Primære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
Patients achieving guideline-recommended treatment
Tidsramme: 3 years
|
Proportion of patients achieving guideline-recommended treatment
|
3 years
|
Sekundære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
Patients achieving optimal functional class
Tidsramme: 3 years
|
Proportion of patients achieving optimal functional class using an evidence-based treatment algorithm
|
3 years
|
Samarbejdspartnere og efterforskere
Det er her, du vil finde personer og organisationer, der er involveret i denne undersøgelse.
Sponsor
Samarbejdspartnere
Efterforskere
- Studiestol: Vallerie McLaughlin, MD, University of Michigan
Datoer for undersøgelser
Disse datoer sporer fremskridtene for indsendelser af undersøgelsesrekord og resumeresultater til ClinicalTrials.gov. Studieregistreringer og rapporterede resultater gennemgås af National Library of Medicine (NLM) for at sikre, at de opfylder specifikke kvalitetskontrolstandarder, før de offentliggøres på den offentlige hjemmeside.
Studer store datoer
Studiestart
1. juni 2011
Primær færdiggørelse (Faktiske)
10. april 2018
Studieafslutning (Faktiske)
10. april 2018
Datoer for studieregistrering
Først indsendt
6. juli 2011
Først indsendt, der opfyldte QC-kriterier
7. juli 2011
Først opslået (Skøn)
8. juli 2011
Opdateringer af undersøgelsesjournaler
Sidste opdatering sendt (Faktiske)
15. august 2018
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
14. august 2018
Sidst verificeret
1. august 2018
Mere information
Begreber relateret til denne undersøgelse
Yderligere relevante MeSH-vilkår
- Hjerte-kar-sygdomme
- Karsygdomme
- Luftvejssygdomme
- Lungesygdomme
- Hypertension, lunge
- Forhøjet blodtryk
- Pulmonal arteriel hypertension
- Familiær primær pulmonal hypertension
- Molekylære mekanismer for farmakologisk virkning
- Antihypertensive midler
- Vasodilatorer
- Blodpladeaggregationshæmmere
- Endotelinreceptorantagonister
- Endothelin A-receptorantagonister
- Endothelin B-receptorantagonister
- Iloprost
- Bosentan
- Macitentan
- Selexipag
Andre undersøgelses-id-numre
- AC-052-428
Lægemiddel- og udstyrsoplysninger, undersøgelsesdokumenter
Studerer et amerikansk FDA-reguleret lægemiddelprodukt
Ja
Studerer et amerikansk FDA-reguleret enhedsprodukt
Ingen
Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .
Kliniske forsøg med Pulmonal arteriel hypertension
-
Universitaire Ziekenhuizen KU LeuvenUniversity of Pittsburgh; Sheba Medical Center; Mount Sinai Hospital, Canada og andre samarbejdspartnereRekrutteringTwin Reversal Arterial Perfusion SyndromeSpanien, Tyskland, Israel, Belgien, Holland, Canada, Forenede Stater, Østrig, Frankrig, Italien, Det Forenede Kongerige
-
Nanfang Hospital, Southern Medical UniversityRekrutteringBevacizumab | Hepatecellular carcinoma | QL1706 | RALOX-HAIC (Hepatic Arterial Infusion Chemoterapi med Raltitrexed og Oxaliplatin) | Type VP3/4 Portalvene Tumor Trombose | Iparomlimab og Tuvonralimab-injektionKina
-
VIVUS LLCIkke rekrutterer endnuPulmonal arteriel hypertension | Pulmonal arteriel hypertension (PAH) (WHO Group 1 PH) | Pulmonal arteriel hypertension (PAH) | Pulmonal arteriel hypertension WHO gruppe I | Pulmonal arteriel hypertension PAH
-
Inhibikase TherapeuticsIkke rekrutterer endnuPulmonal arteriel hypertension (PAH)
-
Philipps University MarburgMSD Sharp & Dohme GmbH, GermanyIkke rekrutterer endnu
-
BayerAfsluttet
-
National Taiwan University Hospital Hsin-Chu BranchRekrutteringHypertension, essentiel | Hypertension, maskeretTaiwan
-
Franz Rischard, DOAcceleron Pharma, Inc., a wholly-owned subsidiary of Merck & Co., Inc...Ikke rekrutterer endnuPulmonal hypertension | Pulmonal arteriel hypertension (PAH)Forenede Stater
-
Stanford UniversityNational Heart, Lung, and Blood Institute (NHLBI); University of MichiganIkke rekrutterer endnuPulmonal arteriel hypertension (PAH)Forenede Stater
-
University of Sao Paulo General HospitalRekrutteringPulmonal arteriel hypertension (PAH)Brasilien